-
1
-
-
0028805101
-
Psychopharmacology of central serotonergic systems
-
Baumgarten H.G., Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry. 28:(Suppl. 2):1995;73-79.
-
(1995)
Pharmacopsychiatry
, vol.28
, Issue.SUPPL. 2
, pp. 73-79
-
-
Baumgarten, H.G.1
Grozdanovic, Z.2
-
2
-
-
0027414222
-
Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice
-
Chapman A.G., Al-Zubaidy Z., Meldrum B.S. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur. J. Pharmacol. 231:1993;301-303.
-
(1993)
Eur. J. Pharmacol.
, vol.231
, pp. 301-303
-
-
Chapman, A.G.1
Al-Zubaidy, Z.2
Meldrum, B.S.3
-
5
-
-
0030732238
-
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: Interactions with dopaminergic mechanisms
-
Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology. 133:1997;329-342.
-
(1997)
Psychopharmacology
, vol.133
, pp. 329-342
-
-
Harrison, A.A.1
Everitt, B.J.2
Robbins, T.W.3
-
6
-
-
0031413240
-
Doubly dissociable effects of median- And dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats
-
Harrison A.A., Everitt B.J., Robbins T.W. Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav. Brain Res. 89:1997;135-149.
-
(1997)
Behav. Brain Res.
, vol.89
, pp. 135-149
-
-
Harrison, A.A.1
Everitt, B.J.2
Robbins, T.W.3
-
7
-
-
0028009482
-
Amelioration by aniracetam of abnormalities as revealed in choice reaction performance and shuttle behavior
-
Himori N., Mishima K. Amelioration by aniracetam of abnormalities as revealed in choice reaction performance and shuttle behavior. Pharmacol. Biochem. Behav. 47:1994;214-225.
-
(1994)
Pharmacol. Biochem. Behav.
, vol.47
, pp. 214-225
-
-
Himori, N.1
Mishima, K.2
-
8
-
-
0031832391
-
Treatment of insomnia by concomitant therapy with zopiclone and aniracetam in patients with cerebral infarction, cerebroatrophy. Alzheimer's disease and Parkinson's disease
-
Katsunuma H., Shimizu T., Ogawa K., Kubo H., Ishida H., Yoshihama A. Treatment of insomnia by concomitant therapy with zopiclone and aniracetam in patients with cerebral infarction, cerebroatrophy. Alzheimer's disease and Parkinson's disease. Psychiatry Clin. Neurosci. 52:1994;198-200.
-
(1994)
Psychiatry Clin. Neurosci.
, vol.52
, pp. 198-200
-
-
Katsunuma, H.1
Shimizu, T.2
Ogawa, K.3
Kubo, H.4
Ishida, H.5
Yoshihama, A.6
-
9
-
-
0030879790
-
Enhancement of contextual fear-conditioning by putative (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice
-
Lu Y., Wehner J.M. Enhancement of contextual fear-conditioning by putative (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice. Brain Res. 768:1997;197-207.
-
(1997)
Brain Res.
, vol.768
, pp. 197-207
-
-
Lu, Y.1
Wehner, J.M.2
-
10
-
-
0031032954
-
AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo
-
Maione S., Rossi F., Biggs C.S., Fowler L.J., Whitton P.S. AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo. Neurochem. Int. 30:1997;299-304.
-
(1997)
Neurochem. Int.
, vol.30
, pp. 299-304
-
-
Maione, S.1
Rossi, F.2
Biggs, C.S.3
Fowler, L.J.4
Whitton, P.S.5
-
11
-
-
0031658795
-
Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter
-
Maione S., Palazzo E., de Novellis V., Stella L., Leyva J., Rossi F. Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;411-417.
-
(1998)
Naunyn-Schmiedeberg's Arch. Pharmacol.
, vol.358
, pp. 411-417
-
-
Maione, S.1
Palazzo, E.2
De Novellis, V.3
Stella, L.4
Leyva, J.5
Rossi, F.6
-
12
-
-
0003145718
-
Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity
-
Martin J.R., Haefely W.E. Pharmacology of aniracetam: A novel pyrrolidinone derivative with cognition enhancing activity. Drug Invest. 5:(Suppl. 1):1993;4-49.
-
(1993)
Drug Invest.
, vol.5
, Issue.SUPPL. 1
, pp. 4-49
-
-
Martin, J.R.1
Haefely, W.E.2
-
13
-
-
0031843091
-
Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam
-
Nakamura K., Kurasawa M., Tanaka Y. Scopolamine model of delirium in rats and reversal of the performance impairment by aniracetam. Drug Dev. Res. 43:1998;85-97.
-
(1998)
Drug Dev. Res.
, vol.43
, pp. 85-97
-
-
Nakamura, K.1
Kurasawa, M.2
Tanaka, Y.3
-
14
-
-
0032567796
-
Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam
-
Nakamura K., Kurasawa M., Tanaka Y. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. Eur. J. Pharmacol. 342:1998;127-138.
-
(1998)
Eur. J. Pharmacol.
, vol.342
, pp. 127-138
-
-
Nakamura, K.1
Kurasawa, M.2
Tanaka, Y.3
-
15
-
-
0032837169
-
Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam
-
Nakamura K., Shirane M. Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam. Eur. J. Pharmacol. 380:1999;81-89.
-
(1999)
Eur. J. Pharmacol.
, vol.380
, pp. 81-89
-
-
Nakamura, K.1
Shirane, M.2
-
16
-
-
0027098027
-
Excitatory amino acids and neuronal plasticity: Modulation of AMPA receptors as a novel substrate for the action of nootropic drugs
-
Nicoletti F., Casabona G., Genazzani A.A., Copani A., Aleppo G., Canonico P.L., Scapagnini U. Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs. Func. Neurol. 7:1992;413-422.
-
(1992)
Func. Neurol.
, vol.7
, pp. 413-422
-
-
Nicoletti, F.1
Casabona, G.2
Genazzani, A.A.3
Copani, A.4
Aleppo, G.5
Canonico, P.L.6
Scapagnini, U.7
-
17
-
-
0000307030
-
Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Double-blind trial in placebo
-
Otomo E., Hirai S., Terashi A., Hasegawa K., Tazaki Y., Araki G., Ito E., Nishimura T., Furukawa T. Clinical usefulness of aniracetam for psychiatric symptoms in patients with cerebrovascular disorders: Double-blind trial in placebo. J. Clin. Exp. Med. 156:1991;143-187.
-
(1991)
J. Clin. Exp. Med.
, vol.156
, pp. 143-187
-
-
Otomo, E.1
Hirai, S.2
Terashi, A.3
Hasegawa, K.4
Tazaki, Y.5
Araki, G.6
Ito, E.7
Nishimura, T.8
Furukawa, T.9
-
18
-
-
0027216836
-
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells
-
Pizzi M., Fallacara C., Arrighi V., Memo M., Spano P. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J. Neurochem. 61:1993;683-689.
-
(1993)
J. Neurochem.
, vol.61
, pp. 683-689
-
-
Pizzi, M.1
Fallacara, C.2
Arrighi, V.3
Memo, M.4
Spano, P.5
-
19
-
-
0033012485
-
5-HT receptor knockout mice: Pharmacological tools or models of psychiatric disorders
-
Scearce-Levie K., Chen J.P., Gardner E., Hen R. 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders. Ann. NY Acad. Sci. 868:1999;701-715.
-
(1999)
Ann. NY Acad. Sci.
, vol.868
, pp. 701-715
-
-
Scearce-Levie, K.1
Chen, J.P.2
Gardner, E.3
Hen, R.4
-
20
-
-
0031988874
-
Influence of excitatory amino acids on basal and sensory stimuli-induced release of 5-HT in the locus coeruleus
-
Singewald N., Kaehler S.T., Hemeida R., Philippu A. Influence of excitatory amino acids on basal and sensory stimuli-induced release of 5-HT in the locus coeruleus. Br. J. Pharmacol. 123:1998;746-752.
-
(1998)
Br. J. Pharmacol.
, vol.123
, pp. 746-752
-
-
Singewald, N.1
Kaehler, S.T.2
Hemeida, R.3
Philippu, A.4
-
22
-
-
0030837833
-
Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain
-
Tao R., Ma Z., Auerbach S.B. Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain. Br. J. Pharmacol. 121:1997;1707-1715.
-
(1997)
Br. J. Pharmacol.
, vol.121
, pp. 1707-1715
-
-
Tao, R.1
Ma, Z.2
Auerbach, S.B.3
-
23
-
-
0028982092
-
Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: A critical reappraisal of the clinical data
-
Tuinier S., Verhoeven W.M., van Praag H.M. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. Int. Clin. Psychopharmacol. 10:1995;147-156.
-
(1995)
Int. Clin. Psychopharmacol.
, vol.10
, pp. 147-156
-
-
Tuinier, S.1
Verhoeven, W.M.2
Van Praag, H.M.3
-
24
-
-
0028150875
-
Tonic desensitization of hippocampal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo
-
Whitton P.S., Maione S., Biggs C.S., Fowler L.J. Tonic desensitization of hippocampal alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo. Neuroscience. 63:1994;945-948.
-
(1994)
Neuroscience
, vol.63
, pp. 945-948
-
-
Whitton, P.S.1
Maione, S.2
Biggs, C.S.3
Fowler, L.J.4
-
25
-
-
0027309068
-
Effects of lesions of the ascending 5-hydroxytryptamine pathways on choice between delayed reinforcers
-
Wogar M.A., Bradshaw C.M., Szabadi E. Effects of lesions of the ascending 5-hydroxytryptamine pathways on choice between delayed reinforcers. Psychopharmacology. 111:1993;239-243.
-
(1993)
Psychopharmacology
, vol.111
, pp. 239-243
-
-
Wogar, M.A.1
Bradshaw, C.M.2
Szabadi, E.3
|